Journal of Medical VirologyMicrobiologyPeer-reviewed journal article
Utility of recombinant envelope domain III as a diagnostic antigen for the specific detection of Kyasanur Forest Disease
Sayad HafeeziD, Rajeshwara N. AchuriD, Vivek VijayiD, Easwaran SreekumariD, Asha SrinivasaniD, Suchetha KumariiD, Nayaka Boramuthi ThippeswamyiD
Abstract
Kyasanur Forest Disease (KFD), commonly known as "monkey fever," is a highly neglected tropical disease caused by the Kyasanur Forest Disease Virus (KFDV). KFD is endemic to Western Ghats of Karnataka, India, with seasonal outbreaks during December to June every year. As there is no standard treatment regime, KFD can be fatal with a mortality rate of 2-10%. Currently, KFD is detected through a non-specific IgM-ELISA followed by RT-PCR, which often delays diagnosis, leading to increased disease severity and even death. To address this, we focused on developing a specific antigen-based KFD detection. The KFDV Envelope Domain III (EDIII) and Non-Structural 1 (NS1) proteins were chosen as detection markers, cloned, and expressed using pET28a(+) vector in BL-21 (Rosetta) E. coli and purified. These proteins were used to raise polyclonal antibodies in rabbits and the antibody titre was found to be 1:256,000 and 1:512,000 against rEDIII and rNS1 proteins, respectively. Importantly, these polyclonal antibodies showed no cross-reactivity against corresponding dengue virus EDIII and NS1 proteins. Using polyclonal antibodies against rEDIII, we developed sandwich ELISA for the specific detection of KFD, which has demonstrated high specificity and sensitivity. Further, anti-rEDIII polyclonal antibodies also detected full-length KFDV-E protein expressed in mammalian cells, confirming the antibody specificity for the native viral antigen.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 5th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Construction of an Immunoinformatics-Based Multi-Epitope Vaccine Candidate targeting Kyasanur Forest Disease Virus
Sunitha Manjari Kasibhatla, Lekshmi S. Rajan, … Pragya Dhruv Yadav·PeerJPeer-reviewed·Mar 21, 2025
- Advancements in Vaccine Development : A comprehensive design of a Multi-Epitopic Immunodominant Peptide Vaccine Targeting Kyasanur Forest Disease via Reverse Vaccinology
Sarika Baburajan Pillai, Jeyachandran Akshay, … Selvaraj Jagannathan·The Open Biotechnology JournalPeer-reviewed·Feb 20, 2026
- A pigtailed macaque model for Kyasanur Forest disease virus and Alkhurma hemorrhagic disease virus
R. Broeckel, F. Feldmann, … S. Best·bioRxiv·Jun 1, 2021
- A preliminary ecological profile of Kyasanur Forest disease virus hosts among the mammalian wildlife of the Western Ghats, India
M. Walsh, S. Mor, … S. Hossain·bioRxiv·Jan 30, 2020
- Sofosbuvir and its tri-phosphate metabolite inhibit the RNA-dependent RNA polymerase activity of non-Structural protein 5 from the Kyasanur forest disease virus
M. Malik, P. Vijayan, … A. Lakshminarasimhan·bioRxiv·Jun 29, 2022
- Detection of antibodies against a conserved capsid epitope as the basis of a novel universal serological test for foot-and-mouth disease
A. S. Asfor, N. Howe, … T. J. Tuthill·bioRxiv·Oct 8, 2019